High-priced 693 items to be re-evaluated in 2009

Published: 2008-12-29 06:58:00

Updated: 2008-12-29 06:58:00

The Korea Insurance Review and Assessment Service announced on December 23 that it will re-evaluate the economic effectiveness of expensive 693 drugs (583 ingredients) in the first quarter of next year, down 77 items from in the last quarter of this year.

Of the 693 medicines, included in th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK